Knight Therapeutics Inc. ( GUD.TO) - Stock Earnings
GUD.TO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026 BeforeMarket | — / — | — | — / — | — |
GUD.TO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -3.8 million CAD | 121.5 million CAD |
| 2025Q4 | 8.9 million CAD | 133.1 million CAD |
| 2026Q1 | 13.2 million CAD | 148.4 million CAD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GUD.TO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -16.8 million CAD | 328.2 million CAD |
| 2024 | 4.3 million CAD | 371.3 million CAD |
| 2025 | -5.4 million CAD | 450.1 million CAD |
| 2026 Est. | — | — |
GUD.TO
Price: CA$8.46
52 week price:
Earnings Per Share: 0.06 CAD
P/E Ratio: 144.33
Exchange: TOR
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 850.9 million